spacer
home > pmps > our clients
OUR CLIENTS

The magazineís readership is 10,500, targeted directly at strategic decision-makers within pharmaceutical companies and their contract partners across Europe, North America and the rest of the world. Combining editorial integrity with a broad spectrum of topic areas, the magazine has proved an effective advertising medium for organisations wishing to target this dynamic market.

Advertisers in the last issue of PMPS were:

Almac Group

Aesica Pharmaceuticals

American Airlines Cargo

Austrian Cargo

BENEO-Palatinit GmbH

Brecon Pharmaceuticals

Burkert

Canon Communications LLC

Capsugel

CBI

Cryo Store bv

CSafe, LLC

Dales Pharmaceuticals

DSM

ELPRO-BUCHS AG

Emball-iso

Emirates SkyCargo

Enestia Belgium nv/sa

Envirotainer AB

Gate2Tech

 Geodis Wilson

Gerhard Schubert Gmbh

Grifols Partnership

Health Protection Agency

Helvoet Pharma

HPT Hochwertige Pharmatechnik Gmbh & Co KG

Lomapharm

Lyofal

Meadwestvaco

Multisorb Technologies

Nuova Ompi

Nycomed Global Contract Manufacturing

Palletways

Patheon

Pharmintech - Ipack-Ima Spa

Piramal Healthcare

Promens Medical Packaging A/S

R5 Pharmaceuticals Ltd

Rohrer AG

Roquette

Rovi Contract Manufacturing

SCA Cool Logistics

Sensitech

Sigpack Systems AG

SMi Group Ltd

Sofrigam

Solvay Injectables

Stelmi SA

UBM International Media

Uhlmann UK Ltd

VIFOR Pharma

Vindon Scientific Limited

Weiler Engineering, Inc

West Pharmaceutical Services, Inc

 

 

 

 

spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August and November
 
Industry Events

Pharmapack Europe 2018

7-8 February 2018, Hall 7.1, Paris Expo, Porte de Versailles, Paris.

As Europe's dedicated Pharmaceutical Packaging and Drug Delivery event, Pharmapack is the industry's go-to place to kick-off the year.
More info >>

 
News and Press Releases

Charles River Laboratories Acquires KWS BioTest

WILMINGTON, Mass.--(BUSINESS WIRE)--Jan. 11, 2018-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services for immuno-oncology and inflammatory and infectious diseases. The addition of KWS enhances Charles Riverís discovery expertise, with complementary offerings that provide our clients with additional tools in the active therapeutic research areas of oncology and immunology.
More info >>

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement